Home › Funds › ACORN CAPITAL ADVISORS, LLC › ANTX
ACORN CAPITAL ADVISORS, LLC position in ANTX
AN2 THERAPEUTICS INC · Health Care
ACORN CAPITAL ADVISORS, LLC reported holding 1,300,000 shares of ANTX (AN2 THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$6.9M, representing 1.90% of its reported portfolio and ranking #12 among its reported holdings. ACORN CAPITAL ADVISORS, LLC first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ACORN CAPITAL ADVISORS, LLC's ANTX position evolved
ACORN CAPITAL ADVISORS, LLC first disclosed a stake in ANTX in Q3 2026 at 1,300,000 shares (US$6.9M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.30M | $6.92M | New |
About ANTX and 13F data
ANTX (AN2 THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in ANTX — the largest reported positions include Vivo Capital, LLC (US$16.8M), Commodore Capital LP (US$14.2M), Spruce Street Capital LP (US$9.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANTX
- Vivo Capital, LLC 3.15M sh · $16.78M · Q3 2026
- Commodore Capital LP 2.93M sh · $14.20M · Q2 2026
- Spruce Street Capital LP 1.75M sh · $9.32M · Q3 2026
- Almitas Capital LLC 1.47M sh · $7.11M · Q2 2026
- Boxer Capital Management, LLC 749.03K sh · $3.63M · Q2 2026
- Tetragon Partners GP Ltd 603.42K sh · $3.21M · Q3 2026
- Sio Capital Management, LLC 548.10K sh · $2.92M · Q3 2026
- Ally Bridge Group (NY) LLC 526.32K sh · $2.55M · Q2 2026
- Aldebaran Capital, LLC 367.71K sh · $1.96M · Q3 2026
- Prosight Management, LP 350.88K sh · $1.87M · Q3 2026
- Stonepine Capital Management, LLC 350.88K sh · $1.87M · Q3 2026
- ACUTA CAPITAL PARTNERS, LLC 142.05K sh · $755.71K · Q3 2026
More on ACORN CAPITAL ADVISORS, LLC
FAQ
How long has ACORN CAPITAL ADVISORS, LLC held ANTX?
ACORN CAPITAL ADVISORS, LLC has disclosed ANTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACORN CAPITAL ADVISORS, LLC's current position in ANTX?
As of Q3 2026, ACORN CAPITAL ADVISORS, LLC holds 1.30M shares of ANTX (AN2 THERAPEUTICS INC), valued at $6.92M, representing 1.90% of its reported portfolio and ranking #12.
Has ACORN CAPITAL ADVISORS, LLC been buying or selling ANTX?
In the latest 13F filing (Q3 2026), ACORN CAPITAL ADVISORS, LLC newly opened its position in ANTX.
Which other funds hold ANTX?
Other major institutional holders of ANTX include Vivo Capital, LLC, Commodore Capital LP, Spruce Street Capital LP, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.